tiprankstipranks
pc:missi

Mission Therapeutics

Mission Therapeutics is a clinical-stage biotech company specializing in the development of first-in-class therapeutics that enhance mitophagy to promote cell and organ health. The company focuses on targeting mitochondrial dysfunction, a key factor in various diseases, including Parkinson's disease, acute kidney injury, and heart failure. Their lead candidate, MTX325, is a USP30 inhibitor designed to improve mitochondrial quality and is currently in clinical development for Parkinson's disease.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$13M
Total Amount Raised$13M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$13M
Latest Funding Amount$13M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Main Enterprise Clients

A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Oct 15, 2025
Investment
$13.30M

Investors

Investor Name
Funding Round

Related News and Analysis